Specifically, we separate out those individuals with high and low constellations of MDD risk at age 12 and investigate whether they subsequently differ in levels of CRP, IL-6, and soluble urokinase plasminogen activator receptor (suPAR) at age 18. This evidence concerns the gene CRP and major depressive disorder.